Delivery Order SPE2DB20D2104-SPE2DB24FT47J
Award Date 4/5/24
Potential Completion Date 4/8/24
Potential Value $2.3K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order valued at $8,794.67 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The delivery order is for the supply of TRULICITY 0.75 MG/0.5 ML PEN 0.5ML, a specialty prescription medication. This award is part of Amerisourcebergen Drug Corp's larger prime contract with DLA, an indefinite delivery contract (IDC) valued at...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of TRULICITY 0.75 mg/0.5 ml pens. The $7,965.65 contract has an ultimate completion date of April 2, 2024 and does not utilize any set-aside designations. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceuticals. The contract has a potential value of $2,760.96 and a completion date of January 29, 2024. Amerisourcebergen Drug Corp holds a larger indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,741.68 contract is for the supply of the medication TRULICITY 3 MG/0.5 ML PEN 0.5ML, with a period of performance through February 8, 2024. This delivery order falls under Amerisourcebergen Drug Corp's larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 0.75 MG/0.5 ML PEN 0.5ML pharmaceutical products. The contract, valued at $1,498.68, has a completion date of January 25, 2024. Amerisourcebergen Drug Corp has a long history of providing pharmaceuticals and medical supplies to the Department of Defense through DLA Troop Support Medical contracts, including an...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply the medication Trulicity 0.75 mg/0.5 ml pen 0.5 ml. The contract has a potential value of $15,516.30 and a completion date of March 7, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML. The contract has a potential value of $2,902.80 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is not associated with any set-aside designation. The company also holds an indefinite...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, worth $3,483.36, for the supply of 4565110247 TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. This order is part of Amerisourcebergen's larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML pharmaceutical products. The delivery order, valued at $3,542.40, has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide TRULICITY 1.5 MG/0.5 ML PEN 0.5ML prescription medication. The order, valued at $1,886.82, has a completion date of March 1, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and has no set-aside designation. Additionally, AmerisourceBergen Drug Corp holds an...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FT47JDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the medication TRULICITY 0.75 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,283.17, has an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This delivery order was issued under that larger IDC. No set-aside designation was used for this award.
Generated 7/5/24, 9:19 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 4/5/24 |